Mood disorders - Articles - Page 3

Research Update

Surprise Result for Adherence in Bipolar Disorder

November 9, 2023

Alex Evans, PharmD, MBA. Dr. Evans has no financial relationships with companies related to this material.

Lithium’s reputation as a difficult med may have more to do with branding than reality, according to this large analysis of mood stabilizer adherence.

Research Update

How Does Ketamine Compare to ECT in Treatment-Resistant Depression?

November 9, 2023

Awais Aftab, MD.

Awais Aftab, MD. Dr. Aftab has no financial relationships with companies related to this material.

This study made headlines with its surprising results, but you’ll want to read the fine print to understand how it informs practice.

Research Update

DBT for Borderline Personality Disorder: Is Half the “Dose” Effective?

October 3, 2023

Kate J. Travis, MD

Kate Travis, MD. Dr. Travis has no financial relationships with companies related to this material.

Major depressive disorder, mood disorders, SSRIs, borderline personality disorder

RESEARCH UPDATE

Is CBT Really All That Jazz for Depression?

September 28, 2023

Amy Ton, MD,

Amy Ton, MD. Dr. Ton has no financial relationships with companies related to this material.

A comprehensive analysis of over 400 studies involving more than 52,000 individuals with depression evaluated the effectiveness of CBT compared to other treatments.

CARLAT WEBINAR

Psychedelics In Psychiatric Practice

September 12, 2023

Garrett Rossi, MD.

0.50 CME Credits. Despite limitations in current depression and PTSD treatments, there is a renewed interest in the therapeutic potential of these medications, which we'll explore in this webinar.

CLINICAL UPDATE

Mood Stabilizers in Bipolar Disorder: What Therapists Need to Know

September 12, 2023

Daniel Carlat, MD

Daniel Carlat, MD. Vice Chair, Community and Public Sector Psychiatry, Tufts University School of Medicine. Publisher, Carlat Publishing.

Dr. Carlat has no financial relationships with companies related to this material.

Best practices for empowering your patient with the knowledge and strategies they need to make the most of mood stabilizers.

RESEARCH UPDATE

Psychological Benefits of Abstaining from Social Media

September 12, 2023

Michael Posternak, MD.

Dr. Posternak has no financial relationships with companies related to this material.

A look into the impact of abstaining from social media on depression, anxiety, and well-being, with a focus on individuals with at least mild depressive symptoms.

Research Update

Lurasidone vs Quetiapine in Bipolar Depression

September 1, 2023

Kate J. Travis, MD

Kate Travis, MD. Dr. Travis has no financial relationships with companies related to this material.

Both these medications work in bipolar depression, but this analysis compared them head-to-head for a different primary outcome: Cognition in bipolar disorder.

Research Update

Mitochondrial Modulators and Bipolar Depression

September 1, 2023

Simon M. Dosovitz, MD

Simon M. Dosovitz, MD. Dr. Dosovitz has no financial relationships with companies related to this material.

Mitochondria regulate the body’s energy stores, and they are thought to play a causal role in bipolar disorder. This analysis gathered at seven therapies that improve mitochondrial function and looked at how they work in bipolar disorder.

Clinical Update

How to Identify and Treat Prodromal Symptoms of Bipolar Disorder and Schizophrenia

September 1, 2023

José S. Sanchez-Cruz, MD

José S. Sanchez-Cruz, MD. Chief Resident, Department of Psychiatry, NYU Langone Health, New York. Chris Aiken, MD. Editor-in-Chief, The Carlat Psychiatry Report; Assistant Professor, NYU Langone Department of Psychiatry; practicing psychiatrist, Winston-Salem, NC.

Dr. Sanchez-Cruz and Dr. Aiken have no financial relationships with companies related to this material.

Patients with genetic risks for schizophrenia and bipolar disorder often present with prodromal symptoms of the illness, but the most effective treatment may surprise some. It’s not a medication.